| Matthew David Williams, MD | |
|
3289 Woodburn Road, 350 Northern Virginia Pulmonary & Critical Care Assoc P, Annandale, VA 22003 | |
| (703) 641-8616 | |
| (703) 641-9468 |
| Full Name | Matthew David Williams |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 27 Years |
| Location | 3289 Woodburn Road, Annandale, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629084918 | NPI | - | NPPES |
| 010064520 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0101058124 (Virginia) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 0101058124 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Inova Mount Vernon Hospital | Alexandria, VA | Hospital |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
News Archive
Brainware, Inc., the leading provider of intelligent data capture and enterprise search solutions, announced today that a Midwest-based healthcare system has chosen Brainware Distiller™ for the automation of hundreds of thousands of invoices annually in a McKesson ERP environment. This client will be automating a completely manual A/P environment and joins the growing number of healthcare providers, payers, researchers and suppliers who have selected intelligent data capture technology to drive efficiency in their accounts payable process.
The USC Norris Comprehensive Cancer Center (USC Norris) has been designated a Phase I Clinical Trial Center of Excellence by global pharmaceutical company Bristol-Myers Squibb Company. The collaboration will bring a number of new phase I clinical trials to USC Norris, and will enable the cancer center's clinical and basic scientists to provide guidance in early phase drug development and trial design.
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).
An international research team has shown for the first time that carbohydrates on the surface of malaria parasites play a critical role in malaria's ability to infect mosquito and human hosts.
› Verified 2 days ago
| Entity Name | Northern Virginia Pulmonary & Critical Care Assoc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952487142 PECOS PAC ID: 4385635929 Enrollment ID: O20040521000379 |
News Archive
Brainware, Inc., the leading provider of intelligent data capture and enterprise search solutions, announced today that a Midwest-based healthcare system has chosen Brainware Distiller™ for the automation of hundreds of thousands of invoices annually in a McKesson ERP environment. This client will be automating a completely manual A/P environment and joins the growing number of healthcare providers, payers, researchers and suppliers who have selected intelligent data capture technology to drive efficiency in their accounts payable process.
The USC Norris Comprehensive Cancer Center (USC Norris) has been designated a Phase I Clinical Trial Center of Excellence by global pharmaceutical company Bristol-Myers Squibb Company. The collaboration will bring a number of new phase I clinical trials to USC Norris, and will enable the cancer center's clinical and basic scientists to provide guidance in early phase drug development and trial design.
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).
An international research team has shown for the first time that carbohydrates on the surface of malaria parasites play a critical role in malaria's ability to infect mosquito and human hosts.
› Verified 2 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20110104000695 |
News Archive
Brainware, Inc., the leading provider of intelligent data capture and enterprise search solutions, announced today that a Midwest-based healthcare system has chosen Brainware Distiller™ for the automation of hundreds of thousands of invoices annually in a McKesson ERP environment. This client will be automating a completely manual A/P environment and joins the growing number of healthcare providers, payers, researchers and suppliers who have selected intelligent data capture technology to drive efficiency in their accounts payable process.
The USC Norris Comprehensive Cancer Center (USC Norris) has been designated a Phase I Clinical Trial Center of Excellence by global pharmaceutical company Bristol-Myers Squibb Company. The collaboration will bring a number of new phase I clinical trials to USC Norris, and will enable the cancer center's clinical and basic scientists to provide guidance in early phase drug development and trial design.
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).
An international research team has shown for the first time that carbohydrates on the surface of malaria parasites play a critical role in malaria's ability to infect mosquito and human hosts.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew David Williams, MD 3289 Woodburn Road, 350 Northern Virginia Pulmonary & Critical Care Assoc P, Annandale, VA 22003 Ph: (703) 641-8616 | Matthew David Williams, MD 3289 Woodburn Road, 350 Northern Virginia Pulmonary & Critical Care Assoc P, Annandale, VA 22003 Ph: (703) 641-8616 |
News Archive
Brainware, Inc., the leading provider of intelligent data capture and enterprise search solutions, announced today that a Midwest-based healthcare system has chosen Brainware Distiller™ for the automation of hundreds of thousands of invoices annually in a McKesson ERP environment. This client will be automating a completely manual A/P environment and joins the growing number of healthcare providers, payers, researchers and suppliers who have selected intelligent data capture technology to drive efficiency in their accounts payable process.
The USC Norris Comprehensive Cancer Center (USC Norris) has been designated a Phase I Clinical Trial Center of Excellence by global pharmaceutical company Bristol-Myers Squibb Company. The collaboration will bring a number of new phase I clinical trials to USC Norris, and will enable the cancer center's clinical and basic scientists to provide guidance in early phase drug development and trial design.
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).
An international research team has shown for the first time that carbohydrates on the surface of malaria parasites play a critical role in malaria's ability to infect mosquito and human hosts.
› Verified 2 days ago
Thomas Ambrose Mccabe, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: Northern Virginia Pulmonary & Critical Care Assoc. Pc, 3289 Woodburn Road, 350, Annandale, VA 22003 Phone: 703-641-8616 Fax: 703-641-9468 | |
Dr. Allan J. Morrison, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3289 Woodburn Rd, Suite # 200, Annandale, VA 22003 Phone: 703-560-7900 Fax: 703-560-8408 | |
Dr. John K. Kim, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 7700 Little River Tpke Ste 102, Annandale, VA 22003 Phone: 703-752-4623 Fax: 703-762-9978 | |
Aabha Jain, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3289 Woodburn Rd, Suite 200, Annandale, VA 22003 Phone: 703-560-7900 | |
Manisha Reddy, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 7432 Little River Tpke, Annandale, VA 22003 Phone: 703-658-7060 | |
Dr. Vishal Mungal, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3289 Woodburn Rd, Annandale, VA 22003 Phone: 703-641-8616 Fax: 703-641-9468 | |
Dr. Stafford S Goldstein, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 Woodburn Rd, Suite #107, Annandale, VA 22003 Phone: 703-876-0437 Fax: 703-876-0722 |